Printer-friendly version

80,000-SF, Gensler-Designed Building on Track for a November 2024 Delivery  

Future HMH Ambulatory Care Center, January 2024

CLIFTON, N.J. (Jan. 11, 2024) – With steel going up and the parking structure completed for Hackensack Meridian Health’s Ambulatory Care Center at ON3, construction is progressing on track for a November 2024 delivery, announced Prism Capital Partners. Situated on the southeast corner of Metro Boulevard and Route 3 in Clifton, the 80,000-square-foot, state-of-the-art facility will serve as the gateway to the award-winning mixed-use redevelopment. 

Prism’s Eugene Diaz, principal partner, said, “It is exciting to see this much-anticipated campus addition taking shape. Hackensack Meridian Health was our very first tenant at ON3, and its presence has grown here continually with new and expanding operations. We are proud to partner with this healthcare leader on their mission to deliver the highest-quality services to the community.” 

ON3 is also home to Hackensack Meridian Health’s School of Medicine and Center for Discovery and Innovation (an NIH-designated Clinical Research Center). 

Prism Construction Management is developing the four-story Ambulatory Care Center, which will include multi-specialty practice areas and potentially an ambulatory surgical center. Designed by Gensler to provide an end-to-end hospitality-driven patient experience, the facility features a distinctive glass curtain wall façade, double height entry and daylight-enriched spaces. The attached parking structure will offer both convenience and ample space for occupants and visitors.  

When complete, the Ambulatory Care Center will join 1.45 million square feet of fully occupied office and R&D/lab space at ON3, with more than 2 million square feet of additional space planned for the 116-acre site. Occupants also include Eisai Inc., Quest Diagnostics, The Ralph Lauren Corporation, Seton Hall University’s Graduate College of Nursing and School of Health and Medical Sciences, Modern Meadow, and Y-mAbs Therapeutics.  

Prism Capital Partners – which maintains its headquarters at ON3 – has a proven track record of creating value through select real estate investments and developments. Geographically focused in the New Jersey/New York/Connecticut regional market, Prism specializes in identifying, acquiring and creating distinctive, value-added opportunities in the office, R&D, education, retail, industrial and residential sectors. 


About Prism Capital Partners  
310 Kingsland Street, Nutley, NJ 07110      

Access Prism Capital Partners media assets here.  
Follow Prism on LinkedIn, Twitter, Instagram and Facebook       

Media Contacts:   
Sandy Crisafulli / Christine Ziomek   
Caryl Communications   
Phone: 201-796-7788   
Email: /